Skip to NavigationSkip to content

News

The MHRA has warned patients that batches of drugs for Parkinson’s, epilepsy and blood clots have been taken out of the legitimate supply chain...
The UK remains split right down the middle as the Brexit crisis rolls on and on, and while we have been side-tracked from one political wedge to...
This week was diverse as always in terms of news coming out of the pharma industry, but the biggest news was undoubtedly the announcement of a $63...
ImmunoGen has announced that, following an in-depth operational review to “extend the company’s cash runway”, it will be implemented a range of...
Janssen’s Darzalex (daratumumab) has secured FDA approval in combination with lenalidomide and dexamethasone for the treatment of newly diagnosed...
Dr Scott Gottlieb, who stepped down from his role as the 23rd Commissioner of the FDA earlier this year, has been elected to the Board of Directors...
A major new review published in The Lancet has supported the effectiveness of the human papilloma virus (HPV) vaccine in developed nations in...
Regeneron Pharmaceuticals and Sanofi have revealed that their dual IL-4 and IL-13 inhibitor Dupixent (dupilumab) has secured FDA approval in the US...
The European Commission has awarded marketing approval to Sixmo, a subdermal buprenorphine implant from Titan Therapeutics and Molteni, in all 28...
AstraZeneca has lifted the curtain on new Phase 3 data for Imfinzi (durvalumab) in the first-line treatment of extensive-stage small cell lung...
Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches